Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.5M | 21.9M | 15.0M | 7.9M |
| Cost of revenue | 12.0M | 17.8M | 12.2M | 7.5M |
| Gross profit | -4.5M | 4.1M | 2.9M | 398K |
| Operating expense | ||||
| Research & development | 961K | 1.2M | 1.0M | 798K |
| Selling general and admin | 2.3M | -3.3M | 2.0M | 2.0M |
| Other operating expenses | — | — | — | — |
| Operating income | -7.7M | 574K | -165K | -2.4M |
| Non operating interest income | ||||
| Income | 537K | -47K | 79K | 261K |
| Expense | 878K | -454K | 654K | 650K |
| Other income expense | — | — | — | — |
| Pretax income | -8.1M | -982K | -740K | -2.8M |
| Tax provision | 0 | -183K | 204K | -192K |
| Net income | -8.1M | -799K | -944K | -2.6M |
| Basic EPS | -0.1 | — | 0.0 | 0.0 |
| Diluted EPS | -0.1 | — | 0.0 | 0.0 |
| Basic average shares | 62M | — | 47.2M | 65.2M |
| Diluted average shares | 62M | — | 47.2M | 65.2M |
| EBITDA | 912K | 5.9M | 6.1M | 2.6M |
| Net income from continuing op. | -8.1M | -799K | -944K | -2.6M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |